|
US4443340A
(en)
|
1981-10-09 |
1984-04-17 |
Betz Laboratories, Inc. |
Control of iron induced fouling in water systems
|
|
US5100899A
(en)
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
|
JPH04230389A
(ja)
|
1990-07-16 |
1992-08-19 |
American Home Prod Corp |
ラパマイシン誘導体
|
|
US5023262A
(en)
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
|
ZA924953B
(en)
|
1991-07-25 |
1993-04-28 |
Univ Louisville Res Found |
Method of treating ocular inflammation
|
|
KR970007322B1
(ko)
|
1991-12-19 |
1997-05-07 |
미쓰이도오아쓰 가가쿠 가부시키가이샤 |
폴리히드록시 카르복실산 및 그 제조방법
|
|
US5177203A
(en)
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
|
US5242910A
(en)
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
|
US5536729A
(en)
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5527907A
(en)
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
|
EP1525858A1
(en)
*
|
1995-06-07 |
2005-04-27 |
Durect Corporation |
High viscosity liquid controlled delivery system
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US5989591A
(en)
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
|
DE60231862D1
(de)
|
2001-02-23 |
2009-05-20 |
Genentech Inc |
Erodierbare polymere zur injektion
|
|
CN1684663A
(zh)
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
|
SI1539157T1
(sl)
|
2002-09-18 |
2013-11-29 |
Trustees Of The University Of Pennsylvania |
Rapamicin za uporabo pri inhibiciji ali preprečevanju horoidalne neovaskularizacije
|
|
US7368126B2
(en)
|
2002-11-06 |
2008-05-06 |
Guohua Chen |
Controlled release depot formulations
|
|
EP2218448B1
(en)
|
2002-12-13 |
2015-09-23 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
|
WO2004081196A2
(en)
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
|
JP2007505932A
(ja)
|
2003-09-18 |
2007-03-15 |
マクサイト， インコーポレイテッド |
経強膜送達
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
DK2767292T3
(en)
*
|
2004-09-17 |
2016-12-19 |
Durect Corp |
RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB
|
|
MX2007003968A
(es)
|
2004-10-01 |
2008-03-04 |
Ramscor Inc |
Composiciones de farmaco de liberacion sostenida convenientemente implantables.
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
CA2602525A1
(en)
|
2005-03-21 |
2006-09-28 |
Macusight, Inc. |
Drug delivery systems for treatment of diseases or conditions
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
KR101478164B1
(ko)
|
2006-02-09 |
2014-12-31 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
AU2007230964B2
(en)
|
2006-03-23 |
2012-07-19 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
CN1973822A
(zh)
|
2006-12-20 |
2007-06-06 |
山东蓝金生物工程有限公司 |
一种含雷帕霉素的抗癌组合物
|
|
EP2120859B1
(en)
|
2006-12-21 |
2013-11-20 |
Stryker Corporation |
Sustained-release formulations comprising bmp-7 crystals
|
|
CN101677952B
(zh)
|
2007-05-18 |
2012-12-05 |
杜雷科特公司 |
改进的贮库制剂
|
|
EP2187743B1
(en)
*
|
2007-08-16 |
2014-07-30 |
Santen Pharmaceutical Co., Ltd |
Rapamycin formulations for treatment of age related macular degeneration
|
|
EP2067471B1
(en)
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
WO2009100222A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Qps Llc |
Non-polymeric compositions for controlled drug delivery
|
|
US20120114637A1
(en)
|
2009-05-04 |
2012-05-10 |
Santen Pharmaceutical Co., Ltd. |
Mtor pathway inhibitors for treating ocular disorders
|
|
CN105748402B
(zh)
*
|
2010-11-24 |
2022-06-03 |
杜雷科特公司 |
生物可降解的药物递送组合物
|
|
TW201334791A
(zh)
|
2011-11-23 |
2013-09-01 |
杜瑞克公司 |
輻射滅菌之可生物降解之藥物遞送組合物
|
|
JP6282231B2
(ja)
|
2012-01-23 |
2018-02-21 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
固化するデポー形成の注入可能な薬物製剤に懸濁される持続放出された生分解性または生体侵食性微小球または微小粒子
|
|
WO2014164754A1
(en)
*
|
2013-03-11 |
2014-10-09 |
Durect Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
HK1220445A1
(zh)
|
2013-03-15 |
2017-05-05 |
Durect Corporation |
具有摇溶性以及增强的溶解再现性和稳定性的组合物
|
|
CA2913336C
(en)
|
2013-05-24 |
2020-12-15 |
Icon Bioscience, Inc. |
Use of sustained release dexamethasone in post-cataract surgery inflammation
|
|
US11065201B2
(en)
|
2014-11-21 |
2021-07-20 |
Technical University Of Denmark |
Gel formulations for local drug release
|
|
HK1246641A1
(zh)
|
2015-03-18 |
2018-09-14 |
参天制药株式会社 |
缓释性医药组合物
|
|
JP6872322B2
(ja)
|
2015-07-01 |
2021-05-19 |
参天製薬株式会社 |
クエン酸エステルを含有するデポ剤
|
|
CN109310680B
(zh)
|
2016-06-30 |
2022-11-01 |
度瑞公司 |
长效配制物
|
|
EP3565553B1
(en)
|
2017-01-06 |
2023-04-26 |
Santen Pharmaceutical Co., Ltd. |
Intratumoral administration of sirolimus for treatment of prostate cancer
|